<html><head><script id="decision-support-view" type="application/json">{
  "dsViewId": "SSIGN_ccRCC.v1",
  "language": {
    "originalLanguage": {
      "terminologyId": {
        "name": "ISO_639-1",
        "value": "ISO_639-1"
      },
      "codeString": "en"
    }
  },
  "decisionSupportViewDefinitions": {
    "sv": {
      "name": "SSIGN klarcellig njurcancer",
      "description": "SSIGN Score är ett instrument för prognostiskt bedömning vid klarcellig njurcancer, efter radikal nefrektomi."
    },
    "en": {
      "name": "SSIGN ccRCC",
      "description": "Prediction of the progression of clear cell renal cell carcinoma after radical nephrectomy"
    }
  },
  "resourceDescription": {
    "originalAuthor": {
      "date": "2017-06-25",
      "name": "Syeeda S Farruque",
      "organisation": "Cambio Healthcare Systems",
      "email": "models@cambiocds.com"
    },
    "otherContributors": [
      "Dennis Forslund, Cambio Healthcare Systems"
    ],
    "lifecycleState": "Author draft",
    "details": {
      "sv": {
        "purpose": "SSIGN (Stage, Size, Grade, Necrosis) score är endast applicerbar på klarcellig njurcancer.",
        "keywords": [
          "SSIGN",
          "klarcellig njurcancer",
          "fuhrman nuclear grade",
          "njurcancer",
          "cancer",
          "onkologi"
        ],
        "use": "SSIGN score används för att komplettera andra graderingssystem med hjälp av specifika kliniska, patologiska fynd. Verktyget är endast applicerbart på klarcellig njurcancer. Instrumentet baseras på följande faktorer:\n\n- Patologiskt T-stadium (i enlighet med TNM-riktlinjer, 2002): pT1-pT4, poäng 0-4\n- Regionalt lymfkörtelengagemang (i enlighet med TNM-riktlinjer, 2002): pNx/pN0 eller pN1/pN2, poäng 0/2 \n- Metastaser (i enlighet med TNM-riktlinjer, 2002): M0 eller M1, poäng 0/4\n- Gradering enligt Fuhrman Nuclear Grade: grad 1/2 (0p), 3 (1p), 4 (2p)\n- Tumörstorlek: \u003c5 cm (0p) eller ≥5 cm (+2p)\n- Förekomst av tumörnekros: Nej (0p) eller Ja (1p)\n\nSlutlig poängsumma uppgår till maximalt 17p.\n\nResultatet tolkas enligt:\n\n\t% uppskattad överlevnad, cancer-specifik\nSSIGN Score \t   År 1      År 3      År 5      År 7      År 10\n0 - 2 \t   99.7      98.7      97.3      96 \t   93.6\n3 - 4 \t   98.1      93.4      89.8 \t  84 \t   77.9\n5 - 6 \t   92.9      83.8      74.1 \t  65 \t   57.3\n7 - 9 \t   76.5      46.9      38.6 \t  29 \t   25.9\n≥ 10 \t   43.3      21.9      19.2 \t  19.2 \t   19.2\n",
        "misuse": "Endast avsedd för klarcellig njurcancer.\n\nVidare utredning och bruk av andra instrument rekommenderas för sammanvägd bild.",
        "copyright": "© Cambio Healthcare Systems"
      },
      "en": {
        "purpose": "The SSIGN (Stage, Size, Grade and Necrosis) score only applies to any stage of clear cell renal cell carcinoma (RCC).",
        "keywords": [
          "SSIGN",
          "clear cell renal cell carcinoma",
          "fuhrman nuclear grade",
          "oncology"
        ],
        "use": "The SSIGN score uses more specific clinical and pathological details to help improve on just using the staging and tumor grade in other systems alone. This tool only applies to clear cell Renal Cell Carcinoma (ccRCC). The scores in this tool are related to the following variables:\n\n- Pathological T category (per 2002 TNM staging guidelines): pT1 to pT4 with score ranges from 0 to 4\n- Regional lymph node status (per 2002 TNM staging guidelines): pNx/pN0 or pN1/pN2 with scores 0 or 2\n- Metastasis category (per 2002 TNM staging guidelines): M0 or M1 with scores 0 or 4\n- Tumour size: \u003c5 cm (0) or ≥5 cm (+2)\n- Tumour (nuclear) grade (taken from the Fuhrman Nuclear Grade score): grades 1/2, 3 or 4 (scores 0, 1 or 3)\n- Tumour necrosis present: No (0) or Yes (+2)\n\nThe scores range from 0 to 17\nSurvival scores are:\n\nPredicted Outcomes\n\t% estimated cancer-specific survival rates\nSSIGN Score \t Year 1 \tYear 3 \tYear 5 \tYear 7 \tYear 10\n0 - 2 \t                   99.7 \t98.7 \t97.3 \t 96 \t 93.6\n3 - 4 \t                   98.1 \t93.4 \t89.8 \t 84 \t 77.9\n5 - 6 \t                   92.9 \t83.8 \t74.1 \t 65 \t 57.3\n7 - 9 \t                   76.5 \t46.9 \t38.6 \t 29 \t 25.9\n≥ 10 \t                   43.3 \t21.9 \t19.2 \t 19.2 \t 19.2",
        "misuse": "Don\u0027t use on non-clear cell types of RCC.\n\nIt is recommended not to rely on this tool on its own but to include the use of other prognostic tools and further investigation to suppliment the results of this tool.",
        "copyright": "© Cambio Healthcare Systems"
      }
    },
    "otherDetails": {
      "references": "Ref. 1: Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumour stage, size, grade and necrosis: the SSIGN score. J Urol 2002; 168:2395–400."
    }
  },
  "alertGuideIds": [],
  "executionGuideIds": [
    "SSIGN_Assessment.v1",
    "SSIGN_ccRCC.v1"
  ],
  "alertBindings": {},
  "termDefinitions": {
    "sv": {
      "id": "sv",
      "terms": {
        "vt0001": {
          "id": "vt0001",
          "text": "Referenser"
        }
      }
    },
    "en": {
      "id": "en",
      "terms": {
        "vt0001": {
          "id": "vt0001",
          "text": "References"
        }
      }
    }
  },
  "resultTemplates": []
}</script></head><body></body></html>